Results 171 to 180 of about 11,702,249 (329)

Electrical triggering of earthquakes: results of laboratory experiments at spring-block models [PDF]

, 2017
В. А. Новиков, V. I. Okunev, V. N. Klyuchkin, Jing Liu‐Zeng, Yuri Ruzhin, Xuhui Shen   +5 more
openalex   +1 more source

4D Beam Tomography at the UCLA Pegasus Laboratory

, 2021
Veronica Guo, Paul Denham, P. Musumeci, Alexander Ody, Youna Park   +4 more
openalex   +1 more source

Potential therapeutic targeting of BKCa channels in glioblastoma treatment

Molecular Oncology, EarlyView.
This review summarizes current insights into the role of BKCa and mitoBKCa channels in glioblastoma biology, their potential classification as oncochannels, and the emerging pharmacological strategies targeting these channels, emphasizing the translational challenges in developing BKCa‐directed therapies for glioblastoma treatment.
Kamila Maliszewska‐Olejniczak, Karolina Pytlak, Sandra Jaworowska, Bogusz Kulawiak, Piotr Bednarczyk   +4 more
wiley   +1 more source

Investigating the Sudan virus outbreak in Uganda through the deployment of a mobile laboratory. [PDF]

BMC Infect Dis
Pimundu G, Muyigi T, Nambozo EJ, Okiira C, Kanamwanji B, Nalwanga R, Sekate J, Mugabe R, Naiga J, Sewanyana I, Lutwama J, Balinandi S, Kaleebu P, Aceng JR, Atwiine D, Mwebesa H, Bosa HK, Kagirita A, Olaro C, Nsawotebba A, Achol E, Lagu H, Nzeyimana E, May J, Gehre F, Affara M, Nabadda S.   +26 more
europepmc   +1 more source

Laboratory preparedness in EU/EEA countries for detection of novel avian influenza A(H7N9) virus, May 2013 [PDF]

, 2014
Eeva Broberg, Dmitriy Pereyaslov, Marc Struelens, Daniel Palm, Adam Meijer, Joanna Ellis, Maria Zambon, John W. McCauley, R. S. Daniels   +8 more
openalex   +1 more source

Laboratory

American Journal of Public Health and the Nations Health, 1934
openaire   +3 more sources

Effective therapeutic targeting of CTNNB1‐mutant hepatoblastoma with WNTinib

Molecular Oncology, EarlyView.
WNTinib, a Wnt/CTNNB1 inhibitor, was tested in hepatoblastoma (HB) experimental models. It delayed tumor growth and improved survival in CTNNB1‐mutant in vivo models. In organoids, WNTinib outperformed cisplatin and showed enhanced efficacy in combination therapy, supporting its potential as a targeted treatment for CTNNB1‐mutated HB.
Ugne Balaseviciute, Júlia Huguet‐Pradell, Jordi Abril‐Fornaguera, Albert Gris‐Oliver, Alex Rialdi, Elisa Fernández‐Martínez, Carla Montironi, Vanessa Del Pozo, Peter Houghton, Laura Zanatto, Agavni Mesropian, Ieva Keraite, Swan Thung, Carolina Armengol, Pau Sancho‐Bru, Ernesto Guccione, Roser Pinyol, Josep M. Llovet   +17 more
wiley   +1 more source

Using audio-visual material to enhance laboratory practicals

Journal of Teaching and Learning with Technology, 2014
Jennifer Schneider, Irene Munro, Siva Krishnan   +2 more
doaj   +1 more source

Addressing the Clinical Workforce Shortage by Retaining the Tenured Laboratory Professionals. [PDF]

Sage Open Pathol
Chiou PZ, Mulder L.
europepmc   +1 more source

Exploiting metabolic adaptations to overcome dabrafenib treatment resistance in melanoma cells

Molecular Oncology, EarlyView.
We show that dabrafenib‐resistant melanoma cells undergo mitochondrial remodeling, leading to elevated respiration and ROS production balanced by stronger antioxidant defenses. This altered redox state promotes survival despite mitochondrial damage but renders resistant cells highly vulnerable to ROS‐inducing compounds such as PEITC, highlighting redox
Silvia Eller, Susanne Ebner, Carmen Haselrieder, Julia K. Günther, Astrid Drasche, Sophie Strich, Chiara Volani, Andrea Medici, Aleksandar Nikolajevic, Alex Deltedesco, Johannes E. Sigmund, Michael J. Blumer, Martin Hermann, Johanna Vanacker, Gerald Brandacher, Eduard Stefan, Omar Torres‐Quesada, Jakob Troppmair   +17 more
wiley   +1 more source